Alzamend Neuro And 2 Other Stocks Under $5 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at Alzamend Neuro, Mobile Infrastructure, and Conn's have recently made significant stock purchases, signaling potential confidence in their companies' futures. Conn's reported a narrower Q4 loss than expected, Mobile Infrastructure is preparing for its Q1 2024 earnings release, and Alzamend Neuro received FDA approval to proceed with a PTSD study.
April 24, 2024 | 10:54 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alzamend Neuro's Director Milton C Ault III acquired 1,000 shares after receiving FDA approval for a PTSD study.
The insider purchase at Alzamend Neuro, following the FDA's approval to proceed with a PTSD study, signals strong insider belief in the company's future prospects, likely resulting in a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Mobile Infrastructure's CEO Manuel Chavez III bought 5,442 shares ahead of its Q1 2024 earnings release.
The CEO's purchase of Mobile Infrastructure shares before the Q1 2024 earnings release may indicate insider confidence in the upcoming financial results, potentially leading to a positive short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Conn's Director Douglas H Martin bought 10,817 shares, following a Q4 earnings report that beat expectations.
The insider purchase at Conn's, combined with a better-than-expected Q4 earnings report, suggests a positive outlook for the company, likely leading to a short-term positive impact on its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90